Association of inflammatory bowel disease with asthma risk: A nationwide cohort study

Allergy and Asthma Proceedings

Volumn 36, Issue 5, 2015, Pages e92-e98

  Peng, Yi Hao ^a,b   Liao, Wei Chih ^a   Su, Ching Hua ^c   Chen, Hsuan Ju ^a   Hsia, Te Chun ^a,b   Chu, Chia Chen ^a,b   Liu, Chin Jung ^a,b   Kao, Chia Hung ^a,d  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c Taichung Hospital   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASTHMA; COHORT ANALYSIS; COMORBIDITY; CROHN DISEASE; DATA BASE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; RISK FACTOR; ULCERATIVE COLITIS; YOUNG ADULT; INCIDENCE; INFLAMMATORY BOWEL DISEASES; POPULATION GROUP; RISK; TAIWAN;

ADULT; AGED; ASTHMA; COHORT STUDIES; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; POPULATION GROUPS; RETROSPECTIVE STUDIES; RISK; TAIWAN; YOUNG ADULT;

EID: 84942589851     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2015.36.3869     Document Type: Article

References (35)

1. Rothfuss KS, Stange EF, and Herrlinger KR. Extraintestinal manifestations and complications in inflammatory bowel diseases. World J Gastroenterol 12:4819-4831, 2006.
2. Papanikolaou I, Kagouridis K, and Papiris SA. Patterns of airway involvement in inflammatory bowel diseases. World J Gastrointest Pathophysiol 5:560-569, 2014.
3. Tzanakis NE, Tsiligianni IG, and Siafakas NM. Pulmonary involvement and allergic disorders in inflammatory bowel disease. World J Gastroenterol 16:299-305, 2010.
4. Black H, Mendoza M, and Murin S. Thoracic manifestations of inflammatory bowel disease. Chest 131:524-532, 2007.
5. Chuang CH, Lin SH, Chen CY, et al. Increasing incidence and lifetime risk of inflammatory bowel disease in Taiwan: A nationwide study in a low-endemic area 1998-2010. Inflamm Bowel Dis 19:2815-2819, 2013.
6. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142:46-54.e42, quiz e30, 2012.
7. Frieri M. Asthma concepts in the new millennium: Update in asthma pathophysiology. Allergy Asthma Proc 26:83-88, 2005.
8. Frieri M. Advances in the understanding of allergic asthma. Allergy Asthma Proc 28:614-619, 2007.
9. Global strategy for asthma management and prevention. Global Initiative for Asthma. 2012. Available online at http://www.ginasthma.org; accessed January 10, 2015.
10. Song WJ, Kang MG, Chang YS, and Cho SH. Epidemiology of adult asthma in Asia: Toward a better understanding. Asia Pac Allergy 4:75-85, 2014.
11. Subbarao P, Mandhane PJ, and Sears MR. Asthma: Epidemiology, etiology and risk factors. CMAJ 181:E181-E190, 2009.
12. Boulet LP. Influence of comorbid conditions on asthma. Eur Respir J 33:897-906, 2009.
13. Frieri M. Asthma linked with rhinosinusitis: An extensive review. Allergy Rhinol (Providence) 5:41-49, 2014.
14. Ceyhan BB, Karakurt S, Cevik H, and Sungur M. Bronchial hyperreactivity and allergic status in inflammatory bowel disease. Respiration 70:60-66, 2003.
15. Haapamaki J, Roine RP, Turunen U, et al. Increased risk for coronary heart disease, asthma, and connective tissue diseases in inflammatory bowel disease. J Crohns Colitis 5:41-47, 2011.
16. Bernstein CN, Wajda A, and Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: A population-based study. Gastroenterology 129:827-836, 2005.
17. National Health Insurance database. Available online at http://nhird.nhri.org.tw/en/Data-Subsets.html; accessed January 10, 2015.
18. Lin CH, Kadakia S, and Frieri M. New insights into an autoimmune mechanism, pharmacological treatment and relationship between multiple sclerosis and inflammatory bowel disease. Autoimmun Rev 13:114-116, 2014.
19. Kraft SC, Earle RH, Roesler M, and Esterly JR. Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch Intern Med 136:454-459, 1976.
20. Keely S, Talley NJ, and Hansbro PM. Pulmonary-intestinal cross-talk in mucosal inflammatory disease. Mucosal Immunol 5:7-18, 2012.
21. Wang H, Liu JS, Peng SH, et al. Gut-lung crosstalk in pulmonary involvement with inflammatory bowel diseases. World J Gastroenterol 19:6794-6804, 2013.
22. Lilja I, Gustafson-Svard C, Franzen L, and Sjodahl R. Tumor necrosis factor-alpha in ileal mast cells in patients with Crohn's disease. Digestion 61:68-76, 2000.
23. Bischoff SC, Lorentz A, Schwengberg S, et al. Mast cells are an important cellular source of tumour necrosis factor alpha in human intestinal tissue. Gut 44:643-652, 1999.
24. Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol 14:329-342, 2014.
25. Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. J Crohns Colitis 4:28-62, 2010.
26. Thomas PS, and Heywood G. Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma. Thorax 57:774-778, 2002.
27. Scaldaferri F, Vetrano S, Sans M, et al. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis. Gastroenterology 136:585-595.e5, 2009.
28. Danese S. VEGF in inflammatory bowel disease: A master regulator of mucosal immune-driven angiogenesis. Dig Liver Dis 40:680-683, 2008.
29. Capetandes A, Zhuang M, Haque FN, et al. Vascular endothelial growth factor is increased by human pulmonary cells stimulated with Dermatophagoides sp. extract. Allergy Asthma Proc 28:324-330, 2007.
30. Kanazawa H, and Yoshikawa J. A case-control study of bronchial asthma associated with ulcerative colitis: Role of airway microvascular permeability. Clin Exp Allergy 35:1432-1436, 2005.
31. Book DT, Smith TL, McNamar JP, et al. Chronic sinonasal disease in patients with inflammatory bowel disease. Am J Rhinol 17:87-90, 2003.
32. Kaliner MA, Osguthorpe JD, Fireman P, et al. Sinusitis: Bench to bedside. Current findings, future directions. Otolaryngol Head Neck Surg 116:S1-S20, 1997.
33. Zhang Y, and Zhang L. Prevalence of allergic rhinitis in China. Allergy Asthma Immunol Res 6:105-113, 2014.
34. Myrelid P, Dufmats M, Lilja I, et al. Atopic manifestations are more common in patients with Crohn disease than in the general population. Scand J Gastroenterol 39:731-736, 2004.
35. Boneberger A, Weiss EH, Calvo M, and Radon K. Atopic manifestations in patients with ulcerative colitis: A report from Chile. J Investig Allergol Clin Immunol 22:73-75, 2012.